je.st
news
Teva shares slide on generic Copaxone fears
2015-04-20 00:21:19| Biotech - Topix.net
Teva Pharmaceutical Industries shares slid five percent on Sunday after U.S. regulators approved a generic version of its top-selling multiple sclerosis drug and amid reports it was mulling a bid for rival Mylan. Teva's Tel Aviv shares fell to 249.80 shekels late on Sunday, the first day of trading since both news hit the market on Thursday after Israel's market closed for the weekend.
Tags: shares
slide
generic
fears
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||